Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
My Portfolio
Articles published by Opthea Limited
Opthea to Receive US$35M Commitment and Additional US$50M Funding
December 27, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea Receives A$8.8 million R&D Tax Incentive
December 19, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea to Present at the FLORetina 2023 Congress
December 01, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea to Present at the Jefferies 2023 London Healthcare Conference
November 09, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference
October 30, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO
October 27, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea to Participate at the 2023 Euretina Congress
October 02, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 07, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea Successfully Completes Institutional Offer and Increases Capital Raising to A$90.0m (US$57.6 million¹)
August 28, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea Announces “Sozinibercept” as the Nonproprietary Drug Name for OPT-302
July 26, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea to Present at the 2023 Ophthalmology Innovation Summit
July 24, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea to Feature at the American Society of Retina Specialists 2023 Annual Meeting
July 13, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea Announces Departure of Chief Medical Officer and Appointment of Senior Medical Advisor
July 10, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea Appoints Anshul Thakral as Non-Executive Director of the Board
June 08, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea to Present at the Jefferies 2023 Healthcare Conference
May 25, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea to Participate in EF Hutton Hosted Discussion on OPT-302 and the Wet AMD Market
May 17, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea To Present at the JMP Securities Life Sciences Conference
May 08, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea To Participate at the H.C. Wainwright BioConnect Conference at NASDAQ
April 28, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea Receives A$8.7 million R&D Tax Incentive
March 07, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea To Participate in Fireside Chat at Oppenheimer’s 33rd Annual Healthcare Conference
March 06, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea Phase 2b Trial Results of OPT-302 in Combination with Lucentis® for wet AMD Published in the Journal Ophthalmology
February 13, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea To Present at SVB Leerink Global Biopharma Conference
February 06, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea To Present at Sequire Biotechnology Conference
January 30, 2023
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea Announce MST Access Hosted Conference Call with Professor Jason S. Slakter, MD
December 12, 2022
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea to Present at the FLORetina 2022 Congress
December 06, 2022
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea to Present at Jefferies London Healthcare Conference
November 10, 2022
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Opthea Expands Leadership Team with the Appointment of Timothy E. Morris as Chief Financial Officer
October 24, 2022
From
Opthea Limited
Via
GlobeNewswire
Tickers
ASX:OPT
OPT
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.